Lactate Dehydrogenase A
Lactate Dehydrogenase A (LDHA; LDH5), EC 220.127.116.11, is one of five isoforms of the lactate dehydrogenase family. It catalyzes the conversion of pyruvate to lactate under anaerobic conditions and plays a key role in the altered glycolytic metabolism that is a feature of cancer cells. LDHs are tetrameric enzymes comprising two different types of subunit, M and H; different combinations of these subunits result in five separate isoforms. LDHA, which is found mainly in skeletal muscle but also in tumors, consists of four M subunits.
LDHA is overexpressed in a wide range of tumors and is associated with the more aggressive cancer phenotypes and poor prognosis. Expression of LDHA is regulated by hypoxia inducible factor-1 (HIF-1) and the oncogene c-Myc. The enzyme is necessary for tumor maintenance, since cancer cells rely on glycolytic metabolism for energy, whereas it is not essential for normal healthy cells that rely on oxidative phosphorylation. Inhibition of LDHA has been shown in animal models to reduce tumor growth, increase oxidative stress and induce apoptosis. The enzyme is therefore being evaluated as a therapeutic target in cancer metabolism.View all products for Lactate Dehydrogenase A »
|Gene||Species||Gene Symbol||Gene Accession No.||Protein Accession No.|
Literature for Lactate Dehydrogenase A
A collection of over 750 products for cancer research, the guide includes research tools for the study of:
- Cancer Metabolism
- Epigenetics in Cancer
- Receptor Signaling
- Cell Cycle and DNA Damage Repair
- Invasion and Metastasis
Find multiple products by catalog number
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.